Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc. (ISRG)
Compare

Intuitive Surgical, Inc. (ISRG) Average Return on Equity (ROE)

Return on Equity (ROE)

The current return on equity (roe) for Intuitive Surgical, Inc. (ISRG) is 16.02% as of Wednesday, June 10, 2026, shown against its trailing averages.

Average Return on Equity (ROE) Chart

ISRG Return on Equity (ROE) Averages

RETURN ON EQUITY (ROE) CURRENT

16.02%

RETURN ON EQUITY (ROE) TTM

15.07%

RETURN ON EQUITY (ROE) 3Y

13.91%

RETURN ON EQUITY (ROE) 5Y

13.46%

RETURN ON EQUITY (ROE) 10Y

14.06%

RETURN ON EQUITY (ROE) 15Y

15.12%

RETURN ON EQUITY (ROE) 20Y

15.38%

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA
15,638 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
David J. Rosa